Stericycle (NASDAQ: SRCL) is one of 20 public companies in the “Waste Management, Disposal & Recycling Services” industry, but how does it weigh in compared to its rivals? We will compare Stericycle to related businesses based on the strength of its analyst recommendations, institutional ownership, earnings, risk, profitability, dividends and valuation.

Profitability

This table compares Stericycle and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Stericycle -0.79% 13.93% 5.61%
Stericycle Competitors -280.96% -68.14% -14.45%

Institutional and Insider Ownership

94.6% of Stericycle shares are held by institutional investors. Comparatively, 53.0% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by institutional investors. 3.5% of Stericycle shares are held by insiders. Comparatively, 12.3% of shares of all “Waste Management, Disposal & Recycling Services” companies are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Stericycle and its rivals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Stericycle 2 3 6 0 2.36
Stericycle Competitors 46 278 586 14 2.61

Stericycle currently has a consensus target price of $75.90, suggesting a potential upside of 12.68%. As a group, “Waste Management, Disposal & Recycling Services” companies have a potential upside of 8.19%. Given Stericycle’s higher probable upside, equities analysts clearly believe Stericycle is more favorable than its rivals.

Valuation and Earnings

This table compares Stericycle and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Stericycle $3.56 billion $206.35 million -118.17
Stericycle Competitors $850.65 million $28.19 million 162.21

Stericycle has higher revenue and earnings than its rivals. Stericycle is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.

Risk and Volatility

Stericycle has a beta of 0.16, suggesting that its share price is 84% less volatile than the S&P 500. Comparatively, Stericycle’s rivals have a beta of 0.72, suggesting that their average share price is 28% less volatile than the S&P 500.

Summary

Stericycle beats its rivals on 7 of the 13 factors compared.

Stericycle Company Profile

Stericycle, Inc. is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other. The Domestic and Canada RCS and International RCS segments include medical waste disposal, pharmaceutical waste disposal, hazardous waste management, sustainability solutions for expired or unused inventory, secure information destruction of documents and e-media, training and consulting through its Steri-Safe and Clinical Services programs, and other regulatory compliance services. The Domestic CRS segment consists of inbound/outbound communication, automated patient reminders, online scheduling, notifications, product retrievals, product returns and quality audits.

Receive News & Ratings for Stericycle Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc. and related companies with MarketBeat.com's FREE daily email newsletter.